APELLIS PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data
APELLIS PHARMACEUTICALS has filed 28 H-1B labor condition applications from FY 2020 to FY 2024, with 26 certified. The median H-1B salary at APELLIS PHARMACEUTICALS is $150,000, which is 25% higher than the national H-1B median of $120,000.
Salary Analysis
Salary Range
- 10th percentile: $120,800
- 25th percentile: $130,000
- Median: $150,000
- 75th percentile: $180,294
- 90th percentile: $240,000
Wage Level Distribution
- Level I (Entry): 0 (0%)
- Level II (Qualified): 6 (23%)
- Level III (Experienced): 8 (31%)
- Level IV (Expert): 12 (46%)
Trend (2020-2024)
- Starting median: $159,744
- Current median: $130,000
- Growth: -19%
Salary & Hiring Visualizations
Salary Distribution
Distribution of H-1B salaries at APELLIS PHARMACEUTICALS
APELLIS PHARMACEUTICALS's H-1B salaries range from $120,800 to $240,000 (10th-90th percentile), with a median of $150,000. This is 25% above the national H-1B median.
Wage Level Distribution
DOL wage levels affect H-1B lottery priority
APELLIS PHARMACEUTICALS files 100% of H-1B positions at Level II or higher. Higher wage levels receive priority in the H-1B lottery, giving APELLIS PHARMACEUTICALS candidates a competitive advantage.
Median Salary Trend
Year-over-year salary changes
APELLIS PHARMACEUTICALS's median H-1B salary changed by -19% from FY 2020 ($159,744) to FY 2024 ($130,000).
H-1B Filings by Year
Annual hiring activity through H-1B program
APELLIS PHARMACEUTICALS's H-1B filings grew by +33% from FY 2020 to FY 2024. This indicates significant expansion of their H-1B workforce.
Salary by Job Title
Top H-1B job titles at this employer
The highest-volume H-1B role at APELLIS PHARMACEUTICALS is Principal Biostatistician with 3 filings at $147,659 median salary.
Salary by Location
Salary distribution across office locations (sorted by median)
APELLIS PHARMACEUTICALS's largest H-1B hub is Waltham, MA with 17 filings. The highest-paying location is Union City, CA at $195,000 median.
Highest Paying H-1B Roles at APELLIS PHARMACEUTICALS
Ranked by median salary — Unlike "Salary by Job Title" above which shows the most common roles by filing volume, this section ranks all H-1B positions by their median compensation to highlight the best-paying opportunities.
These are the top 10 highest-paying H-1B job titles at APELLIS PHARMACEUTICALS, ranked by median salary. The highest-paying role is Head Of Us Commercial Finance at $240,000 median, which is 60% above the company's overall H-1B median of $150,000.
High-paying H-1B roles typically require advanced technical expertise, specialized domain knowledge, or significant leadership responsibility. Factors influencing top-tier compensation include years of experience, educational credentials (PhD, Master's degrees), rare skill combinations, and market demand for specific technologies. The salary distribution chart below each role shows how compensation varies—wider distributions indicate more salary negotiation flexibility, while narrow peaks suggest standardized pay bands. Senior and principal-level positions consistently command premium salaries due to their strategic impact and scarcity of qualified candidates.
Head Of Us Commercial Finance
1 H-1B filings at APELLIS PHARMACEUTICALS
Senior Manager, Regulatory Information Management
1 H-1B filings at APELLIS PHARMACEUTICALS
Principal Statistical Programmer
1 H-1B filings at APELLIS PHARMACEUTICALS
Principal Biostatistician
3 H-1B filings at APELLIS PHARMACEUTICALS
Regulatory Affairs Manager, Device
2 H-1B filings at APELLIS PHARMACEUTICALS
Manager, Regulatory Information Management
2 H-1B filings at APELLIS PHARMACEUTICALS
Salary data based on 26 certified H-1B labor condition applications at APELLIS PHARMACEUTICALS. Actual compensation may vary based on experience, specific role requirements, and location within the company.
Highest Individual H-1B Salaries at APELLIS PHARMACEUTICALS
Actual filed salaries — These are the 10 highest individual H-1B salary filings at APELLIS PHARMACEUTICALS, representing specific positions (not aggregated medians). These may include executive, highly specialized, or senior leadership roles.
The highest H-1B salary filed at APELLIS PHARMACEUTICALS was $250,000 for a Head Of Financial Planning & Analysis position in Waltham, MA (FY2021). This is 67% higher than the company's median H-1B salary.
Top H-1B salaries often cluster in high cost-of-living metros like San Francisco, New York, and Seattle where prevailing wages are higher. However, executive and specialized roles can command premium compensation regardless of location. These filings represent the upper bound of H-1B compensation at APELLIS PHARMACEUTICALS—actual total compensation may be significantly higher when including stock grants, bonuses, and benefits. Geographic patterns in top salaries often reflect where companies locate their most senior technical talent and leadership positions.
Marker size indicates salary level. Click markers for details.
| Rank | Job Title | Location | Salary | Level | Year |
|---|---|---|---|---|---|
| 1 | Head Of Financial Planning & Analysis | Waltham, MA | $250,000 | IV | FY 2021 |
| 2 | Head Of Us Commercial Finance | Waltham, MA | $240,000 | IV | FY 2020 |
| 3 | Senior Director, Clinical Pharmacology | Waltham, MA | $240,000 | IV | FY 2022 |
| 4 | Director, Global Business Intelligence | Waltham, MA | $215,000 | IV | FY 2022 |
| 5 | Associate Director, Biostatistics | Union City, CA | $195,000 | III | FY 2023 |
| 6 | Associate Director, Statistical Programming | Waltham, MA | $185,000 | IV | FY 2022 |
| 7 | Associate Director, Regulatory Information Management | Waltham, MA | $180,294 | IV | FY 2022 |
| 8 | Associate Director Of Biostatistics | Waltham, MA | $175,000 | IV | FY 2021 |
| 9 | Senior Manager, Regulatory Information Management | Waltham, MA | $159,744 | IV | FY 2020 |
| 10 | Principal Statistical Programmer | Waltham, MA | $155,000 | IV | FY 2020 |
These represent the highest individual salary amounts filed in H-1B labor condition applications. Note: H-1B salary data reflects base compensation only and does not include stock options, RSUs, bonuses, or other benefits which can significantly increase total compensation at tech companies.
Detailed Breakdown
H-1B Job Titles at APELLIS PHARMACEUTICALS
| Job Title | Filings | Median Salary |
|---|---|---|
| Principal Biostatistician | 3 | $147,659 |
| Regulatory Affairs Manager, Device | 2 | $140,000 |
| Manager, Regulatory Information Management | 2 | $130,000 |
| Principal Statistical Programmer | 1 | $155,000 |
| Senior Manager, Regulatory Information Management | 1 | $159,744 |
| Head Of Us Commercial Finance | 1 | $240,000 |
H-1B Locations for APELLIS PHARMACEUTICALS
| Location | Filings | Median Salary |
|---|---|---|
| Waltham, MA | 17 | $155,000 |
| Downingtown, PA | 1 | $147,659 |
| The Colony, TX | 1 | $147,659 |
| Union City, CA | 1 | $195,000 |
| Bensalem, PA | 1 | $130,000 |
| Cinnaminson, NJ | 1 | $150,000 |
| Okemos, MI | 1 | $150,000 |
| Watertown, MA | 1 | $120,800 |
| Louisville, KY | 1 | $154,400 |
| Alpharetta, GA | 1 | $130,000 |
Recent H-1B Filings at APELLIS PHARMACEUTICALS
Sample of 20 recent certified H-1B labor condition applications. This represents a small fraction of APELLIS PHARMACEUTICALS's 26 total certified filings.
| Job Title | Location | Salary | Level | Year |
|---|---|---|---|---|
| Senior Business Analyst | Waltham, MA | $120,994 | III | FY 2024 |
| Research Scientist | Watertown, MA | $120,800 | II | FY 2024 |
| Principal Biostatistician | Louisville, KY | $154,400 | IV | FY 2024 |
| Manager, Regulatory Information Management | Alpharetta, GA | $130,000 | III | FY 2024 |
| Regulatory Affairs Manager, Device | Waltham, MA | $140,000 | II | FY 2023 |
| Associate Director, Biostatistics | Union City, CA | $195,000 | III | FY 2023 |
| Manager, Regulatory Information Management | Bensalem, PA | $130,000 | II | FY 2023 |
| Sr. Manager, Device And Adverse Event Reporting | Cinnaminson, NJ | $150,000 | III | FY 2023 |
| Senior Manager, Distribution Operations | Okemos, MI | $150,000 | III | FY 2023 |
| Regulatory Affairs Manager, Device | Waltham, MA | $140,000 | II | FY 2023 |
| Principal Biostatistician | The Colony, TX | $147,659 | IV | FY 2022 |
| Associate Director, Statistical Programming | Waltham, MA | $185,000 | IV | FY 2022 |
| Senior Director, Clinical Pharmacology | Waltham, MA | $240,000 | IV | FY 2022 |
| Director, Global Business Intelligence | Waltham, MA | $215,000 | IV | FY 2022 |
| Clinical Scientist, Opthalmology | Waltham, MA | $135,000 | II | FY 2022 |
| Senior Specialist - Quality Assurance | Waltham, MA | $105,000 | III | FY 2022 |
| Associate Director, Regulatory Information Management | Waltham, MA | $180,294 | IV | FY 2022 |
| Manager, Regulatory Systems Business Support | Waltham, MA | $125,000 | II | FY 2022 |
| Associate Director Of Biostatistics | Waltham, MA | $175,000 | IV | FY 2021 |
| Head Of Financial Planning & Analysis | Waltham, MA | $250,000 | IV | FY 2021 |
Data source: U.S. Department of Labor LCA Disclosure Files. Showing most recent certified filings.
Frequently Asked Questions about APELLIS PHARMACEUTICALS H-1B Visas
What is the average H-1B salary at APELLIS PHARMACEUTICALS?
The median H-1B salary at APELLIS PHARMACEUTICALS is $150,000, based on 26 certified filings from FY 2020 to FY 2024. This is 25% higher than the national H-1B median salary of $120,000. Compensation at APELLIS PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $130,000 and senior positions reaching $240,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.
Salaries at APELLIS PHARMACEUTICALS range from $120,800 at the 10th percentile to $240,000 at the 90th percentile, showing a $119,200 spread across experience levels and roles. The 25th percentile is $130,000 and the 75th percentile is $180,294.
Does APELLIS PHARMACEUTICALS sponsor H-1B visas?
Yes, APELLIS PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 28 H-1B labor condition applications from FY 2020 to FY 2024, demonstrating ongoing commitment to hiring international talent. With 26 certified applications and a 0% denial rate, APELLIS PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.
In the most recent fiscal year (FY 2024), APELLIS PHARMACEUTICALS filed 4 H-1B applications, with 4 certified and 0 denied. Over 5 years of data, APELLIS PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.
Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.
What is APELLIS PHARMACEUTICALS's H-1B approval rate?
APELLIS PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 28 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating APELLIS PHARMACEUTICALS as a potential H-1B sponsor.
This is an excellent approval rate, indicating APELLIS PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.
What jobs does APELLIS PHARMACEUTICALS sponsor for H-1B?
APELLIS PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 26 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles APELLIS PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.
Most common H-1B job titles at APELLIS PHARMACEUTICALS:
The most frequently sponsored role is Principal Biostatistician with 3 filings at a median salary of $147,659. This is followed by Regulatory Affairs Manager, Device (2 filings) and Manager, Regulatory Information Management.
Where are APELLIS PHARMACEUTICALS's H-1B jobs located?
APELLIS PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where APELLIS PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.
Top APELLIS PHARMACEUTICALS H-1B locations:
The largest H-1B hub for APELLIS PHARMACEUTICALS is Waltham, MA with 17 filings at a median salary of $155,000. The highest-paying location is Union City, CA at $195,000 median. Salaries range from $120,800 to $195,000 across office locations.
How have APELLIS PHARMACEUTICALS's H-1B salaries changed over time?
APELLIS PHARMACEUTICALS's median H-1B salary has changed by -19% from FY 2020 ($159,744) to FY 2024 ($130,000). Tracking salary trends over time reveals how APELLIS PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at APELLIS PHARMACEUTICALS.
Year-by-year breakdown:
- FY 2020: $159,744 (3 certified)
- FY 2021: $147,659 (5 certified)
- FY 2022: $180,294 (8 certified)
- FY 2023: $150,000 (6 certified)
- FY 2024: $130,000 (4 certified)
Salary levels have remained relatively stable at APELLIS PHARMACEUTICALS.
What wage level does APELLIS PHARMACEUTICALS use for H-1B?
APELLIS PHARMACEUTICALS primarily files H-1B applications at Wage Level IV, accounting for 46% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making APELLIS PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.
With 100% of positions at Level II or higher, APELLIS PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.
How does APELLIS PHARMACEUTICALS's H-1B salary compare to other employers?
APELLIS PHARMACEUTICALS's median H-1B salary of $150,000 is 25% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating APELLIS PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare APELLIS PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.
This places APELLIS PHARMACEUTICALS among the higher-paying H-1B sponsors in the industry. Candidates considering H-1B sponsorship should weigh this competitive compensation alongside other factors like role growth, location, and visa processing track record.
How do new H-1B fees and rules affect APELLIS PHARMACEUTICALS's sponsorship?
Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. APELLIS PHARMACEUTICALS's higher proportion of Level III-IV positions (77%) may benefit from wage-based lottery prioritization.
With 26 certified filings, APELLIS PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.
Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.
Companies Similar to APELLIS PHARMACEUTICALS
Employers with similar H-1B salary ranges and filing volumes.
Explore Major H-1B Employers
These top H-1B sponsors have comprehensive salary data and filing history:
View all employers →